Boof, M., Halabi, A., Ufer, M., & Dingemanse, J. (2020). Impact of the organic cation transporter 2 inhibitor cimetidine on the single-dose pharmacokinetics of the glucosylceramide synthase inhibitor lucerastat in healthy subjects. European journal of clinical pharmacology, 76(3), 431-437. https://doi.org/10.1007/s00228-019-02808-9
Chicago Style (17th ed.) CitationBoof, Marie-Laure, Atef Halabi, Mike Ufer, and Jasper Dingemanse. "Impact of the Organic Cation Transporter 2 Inhibitor Cimetidine on the Single-dose Pharmacokinetics of the Glucosylceramide Synthase Inhibitor Lucerastat in Healthy Subjects." European Journal of Clinical Pharmacology 76, no. 3 (2020): 431-437. https://doi.org/10.1007/s00228-019-02808-9.
MLA (9th ed.) CitationBoof, Marie-Laure, et al. "Impact of the Organic Cation Transporter 2 Inhibitor Cimetidine on the Single-dose Pharmacokinetics of the Glucosylceramide Synthase Inhibitor Lucerastat in Healthy Subjects." European Journal of Clinical Pharmacology, vol. 76, no. 3, 2020, pp. 431-437, https://doi.org/10.1007/s00228-019-02808-9.